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Background 
Although the potential of exercise as an adjunct treatment for substance dependence is persuasive in 
theory, few controlled trials have assessed its effectiveness. Existing research has also largely 
focussed on individuals aiming towards, or having already achieved, abstinence. This study employed 
a randomised controlled design in a pilot trial to assess the feasibility, acceptance, and effects of an 
exercise intervention for individuals receiving outpatient heroin-assisted treatment.  
Method 
50 individuals receiving heroin-assisted treatment at a clinic in Switzerland were invited to take part 
in the trial. Participants were randomised to 12 weeks of exercise twice per week, or a corresponding 
duration of non-exercise group activities in a comparison condition. Data on attendance, compliance, 
and numerous psychological and physiological parameters were gathered.  
Results 
24 individuals were willing to take part in the study. 92.3% of the exercise condition (n=13) were 
compliant or semi-compliant with the protocol; by contrast, only 54.6% of participants in the 
comparison condition (n=11) were compliant or semi-compliant (χ2 =7.049; p=.029). Participants in 
the exercise condition significantly increased the number of minutes spent exercising at a high 
intensity level (F(2,44)=3.794; p=.046; η2=.159).  No other significant interaction effects were 
observed.  
Conclusions 
An exercise intervention is a feasible and accepted supplementary therapy to heroin-assisted 
treatment. Participation rates were high, particularly given the outpatient setting. No evidence 
regarding the potential mechanisms of exercise as a therapy modality could be identified. Patients in 
heroin-assisted treatment may require a longer-term exercise programme, specifically targeting 
particular health parameters, before measurable improvements can be observed.  
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1. Introduction 
The recognition that exercise is a fundamental aspect of good human health, which may not only 
prevent many diseases, but also be therapeutically effective, has grown rapidly in the last two 
decades. Numerous studies have reported the positive influence of an exercise regimen for a range 
of illnesses, especially cardiovascular and metabolic diseases (Pattyn, Cornelissen, Eshghi, & Vanhees, 
2013; Taylor et al., 2004). In particular, there has been an increased interest in the potential of 
exercise as an adjunct treatment for mental disorders (Richardson et al., 2005; Rosenbaum, 
Tiedemann, Sherrington, Curtis, & Ward, 2014). The strongest evidence exists for the treatment of 
depression (Blumenthal et al., 2007; Cooney et al., 2013), with certain beneficial effects for anxiety 
disorders and schizophrenia (Callaghan, 2004), although evidence from methodologically robust 
studies is sparse, and frequently less promising than from studies without control conditions ( 
Zschucke, Gaudlitz, & Ströhle, 2013). 
Substance dependence is a mental disorder frequently accompanied by comorbidities such as 
depression, anxiety disorders and personality disorders (Volkow, 2001). It is treated with 
pharmaceutical and therapeutic modalities (in some cases encompassing a withdrawal period) in 
ways similar to those employed for other mental disorders (Kleber et al., 2006). To date, studies 
assessing the potential of exercise as an adjunct treatment for substance use disorders have varied 
considerably in primary outcomes, and in quality.   
Evidence from preclinical studies suggests that, with the exception of alcohol, undertaking exercise 
reduces drug self-administration, escalation, and reinstatement.  A number of mechanisms have 
been posited, most importantly the rewarding properties of exercise due to activation of the 
mesolimbic pathway, the amelioration of striatal dopamine receptor deficits (Robertson et al., 2015), 
and the concurrent reduction of comorbidities which may perpetuate the substance use cycle (Lynch 
et al., 2013). Some authors have speculated that the caloric content of alcohol, and the route of 
administration may account for the inconsistency of studies involving ethanol (Bardo & Compton, 
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2015; Lynch, Peterson, Sanchez, Abel, & Smith, 2013). Though purely speculative, we suggest that 
dopamine release and, possibly, receptor availability, following alcohol administration may differ 
from other substances to a degree which may also contribute to the findings summarised above 
(Nutt, Lingford-Hughes, Erritzoe & Stokes, 2015). 
Evidence from clinical trials, although promising, remains in the early stages. A recent literature 
review reports on eight studies examining exercise as an adjunct treatment for substance use, which 
showed weak evidence for positive effects on a variety of outcome variables (Zschucke, Heinz, & 
Ströhle, 2012) such as increases in days of abstinence(Brown et al., 2010; Burling, Seidner, Robbins-
Sisco, Krinsky, & Hanser, 1992; Collingwood, Reynolds, Kohl, Smith, & Sloan, 1991), decreased heroin 
withdrawal symptoms (Li, Chen, & Mo, 2002), and reduced craving (Buchowski et al., 2011; Roessler, 
2010). The review also speculates that in clinical populations, numerous social, behavioural and 
neurophysiological mechanisms may be implicated in the effects of exercise interventions, although 
no study has examined these in detail. A wide variety of exercise forms, including strength training, 
Qi Gong,  aerobic training using circuits, exercise bikes and treadmills, softball games, volleyball, and 
in some cases a number of these combined, have been employed with frequencies varying from one 
to five times per week. 
Since that review, a pilot randomized controlled trial with 29 individuals currently receiving 
methadone treatment has demonstrated that a video-game based intervention, involving 25 minutes 
of a combination of aerobic training, strength training, and flexibility exercises undertaken 
individually,  is a feasible and acceptable method of exercise participation for this population. 
Participants also significantly reduced their cocaine and opioid use, and experienced improved 
mental wellbeing, although there was no difference between the exercise or control group (Cutter et 
al., 2014). In a study by Dolezal (2013) and colleagues, 39 individuals following inpatient treatment 
for methamphetamine dependence were randomized to an exercise intervention involving three 
hour-long sessions of treadmill running and strength circuits, or a control condition. As well as 
showing the feasibility of the intervention, the exercise group significantly improved VO2max (the 
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maximum volume of oxygen that an individual can use during exercise )(Hawkins, Raven, Snell, Stray-
Gundersen, & Levine, 2007)  and muscle strength (Dolezal et al., 2013). In a subsequent study in this 
population, with the same exercise protocol, heart rate variability improved following eight weeks of 
training (Dolezal et al., 2014). 
Although not a clinical trial, Weiss and colleagues report, based on interviews with recovered or 
relapsed heroin addicts, that participating in exercise, amongst other activities, can be helpful in 
achieving abstinence (Weiss et al., 2014). Further research is also currently in development; Mooney 
(2014) and colleagues are developing an aerobic and resistance training programme, to be 
supervised thrice weekly over an 8-week period following residential treatment for 
methamphetamine dependence, while Trivedi (2011) and colleagues have designed a 12 week 
programme of thrice weekly treadmill-training, followed by 6 months of once-weekly supervised 
sessions for individuals undertaking residential treatment for stimulant abuse. Both studies focus on 
days of abstinence following residential care as the primary outcome (Mooney et al., 2014; Trivedi et 
al., 2011). 
While these studies have shown tentatively promising results, Zschucke (2012) and colleagues note 
that many have been plagued by issues, such as small sample sizes and high drop-out rates, which 
limit their statistical power (Zschucke, Heinz & Ströhle, 2012). Furthermore, to date, all but one of 
the studies have been carried out with individuals already abstinent and not receiving opioid 
substitution therapy, and aiming towards long-term abstinence. It remains to be seen whether an 
exercise programme is feasible, acceptable and effective for individuals for whom abstinence is not a 
current realistic possibility, and who are not in a setting (such as inpatient care), in which regular 
structured exercise can be relatively easily carried out.  
In Switzerland, and a small number of other countries, heroin-assisted treatment (HAT) is offered for 
opioid-addicted individuals who have failed to respond to conventional treatment, such as 
methadone substitution or abstinence-oriented treatment ( Bundesamt für Gesundheit, 2015). 
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Patients are prescribed a dose of clinical-standard heroin (diacetylmorphine), which they inject or 
ingest within the clinic once or twice per day. The principal aim of HAT is to provide patients with a 
treatment modality which will enable them to stabilise their lives, and avoid the illegal behaviour 
which opioid consumption otherwise necessitates (Bundesamt für Gesundheit, 2000). A review of 
studies of HAT in Canada, Switzerland, Germany, the Netherlands, and the United Kingdom, found 
the treatment to be safe, effective in reducing delinquent behaviour and illicit opioid consumption, 
and a valuable, if “last-resort” treatment option (Fischer et al., 2007). The Swiss Department of 
Health lists overall health, and specifically exercise promotion amongst the mid-term aims of HAT ( 
Bundesamt für Gesundheit, 2000). To date, however, the feasibility of integrating an exercise 
programme into this treatment form has not been investigated.   
The aim of the present randomised pilot study was to test the feasibility, acceptability and 
psychological and physiological health effects of an exercise programme in an out-patient HAT 
setting, for opioid-addicted individuals not aiming towards abstinence at the time of the study. In 
order to minimise the potential confounding effects of the intervention being associated with 
contact time with new team leaders, access to typically prohibitively expensive environments, and a 
financial reward, a comparison condition was used in this study. In this way, it is hoped that patient 
attitudes to sport specifically can be disentangled from patient attitudes to new activities and study 
participation in general. In contrast with the majority of other studies in this field, in which 
abstinence was a central outcome, relevant outcomes for individuals in HAT should be seen as 
potential harm reduction measures, such as reduced illicit drug consumption. Four research 
questions were formulated in line with this aim: 
1.1 Can HAT patients be recruited to participate in an RCT of exercise as an adjunct treatment 
modality? 
1.2 Will the exercise group comply with the study protocol? 
1.3 Will the comparison group comply with the study protocol? 
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1.4 Will an exercise programme lead to any alterations or improvements in the above-mentioned 
variables, and will these differences also be found in the comparison group? 
2. Methods 
The study took place between November and February 2014, and was part of larger study into 
exercise as feasible treatment in outpatient opiate substitution therapy.  
2.1 Participants and procedures 
Participants were recruited from a HAT clinic, treating 150 patients, in Basel, Switzerland. 
Participants were recruited via face-to-face contact with study or clinic personnel, and informative 
posters and flyers in the clinic. The sole exclusion criterion was any psychological or physical 
impairment precluding participation in light exercise, a decision made solely by the treatment staff of 
the clinic. In total, 50 patients were deemed capable of taking part, and were invited to join the 
study. Patients who agreed to participate were randomised to either an exercise or comparison 
condition through a blinded process of identical sealed envelopes, stipulating one of the two 
conditions. Patients were informed verbally and in writing that, if they were in the comparison group, 
they would also receive 12 weeks of exercise training immediately upon completion of the study. All 
patients were informed that in addition to drinks and snacks following training, they would receive a 
sports T-shirt, and 100 Swiss francs as reward for participation. Patients were informed that if they 
missed more than five training sessions, this reward would be reduced by four francs for each session 
missed, although even non-compliance with the protocol resulted in a small reward for completion 
of the study measures. All patients provided written informed consent. The study was carried out in 
accordance with the principles of the Declaration of Helsinki, and approval for the trial was obtained 
from the local ethics committee (EKNZ), an independent organisation representing 11 Swiss cantons. 
It is important to note that there is no penalty for use of additional substances in HAT in Switzerland, 
so this would not constitute a reason for reticence in answering questions regarding concomitant 
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substance use. The consumption of other substances was assessed as one of the outcomes of this 
study, as is described further below. 
2.2 Intervention programme 
The exercise condition was designed with regard to feedback received from patients during 
preliminary qualitative investigations. Questionnaires and focus groups were used to determine the 
optimal organisation, content and timing of the programme. Specifically, the questionnaire (N=28) 
revealed that clinic patients were keen to become more physically active, but had a wide variety of 
exercise preferences which frequently overlapped with those activities which other patients refused 
to participate in. The focus group (N=12) was used to determine the optimal days and times for the 
intervention to take place, the importance of location and material provision, and to determine an 
intervention structure which would allow all patients, regardless of physical ability, to participate. 
(Detailed information on these findings appears in a forthcoming publication). In order to provide 
appealing content for all ability levels, two parallel exercise sessions were offered on two evenings 
per week, following dispensing of diacetylmorphine. One session involved moderate to vigorous 
physical activity which varied regularly in terms of content (including climbing, badminton, strength 
training, boxing, dance). The second session involved walking, occasionally with coordination games, 
to include participants with physical limitations or dislike of the other sport activities. Patients could 
decide freely at the start of every session which group they would prefer to join. No specific heart 
rate zone or energy expenditure goals were set for these sessions. Based on patient feedback, it was 
determined that in the pilot phase of research, participation as such, and not the achievement of 
fitness targets, was the appropriate aim for this population. The sessions, and the comparison group 
activities, were overseen by four trained study personnel with a background in sports education.  
The comparison condition was scheduled at the same time and with the same frequency, but without 
a parallel session, as physical impairments did not affect the comparison group activities in the same 
way as they might hinder participation in sports activities. Initially planned activities included board 
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games and painting; at the request of participants, cooking, museum visits and billiard games were 
also included. While some of these activities do include a certain amount of physical movement, as 
they are not “planned, structured and repetitive” (Caspersen, Powell & Christenson, 1985) in the 
manner of exercise training, we feel that their incorporation into the comparison condition does risk 
obscuring any effects of the exercise condition. 
Neither group received advice to change their exercise or substance consumption habits, or were 
given any other form of health advice in the context of the study.  
2.3 Measures 
Data was collected at baseline following randomisation, after 6 weeks, and at the end of the 12 week 
programme. Measurements took place in the clinic during morning and afternoon opening hours. All 
demographic and psychological questionnaires were completed with pen and paper by participants, 
with study personnel guidance. Physiological measures were taken by study personnel and entered 
into the paper case report form immediately. The measures employed in this study were chosen 
primarily on the basis of their validity and reliability in assessing the relevant constructs, with 
consideration given to whether the original questionnaire was in German. However, a particular 
focus was also placed on brevity, as the full questionnaire booklet comprised 13 (one-sided) pages, 
and it was judged that a lengthier booklet might pose an additional hurdle for participants. All 
measures used were also employed in the subsequent stages of this study carried out in a further 
opioid substitution clinic. 
Demographic data concerning age, gender, nationality, highest education level achieved, 
employment/social support status and marital status were reported by each participant. We also 
assessed the daily dose of diacetylmorphine and clinical diagnoses of psychiatric comorbidities from 
the electronic patient file. 
Compliance with the study protocol was categorised as follows: compliant (at least 18 out of 23 
sessions attended); semi-compliant (between 17 and 5 sessions attended); and non-compliant (4 
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sessions or fewer attended). Compliance and non-compliance were defined as approximating 80% 
(or more) and 20% (or less) attendance respectively. The broad semi-compliance category was 
deemed the best way to represent the irregular attendance displayed by certain participants. 
Furthermore, as participants were informed prior to the study that missing more than 5 sessions, or 
attending 4 or fewer, would impact on the financial reward they received, it was felt that this 
categorisation reflected the expectations explicitly communicated to participants in the study, and 
was therefore an appropriate approach. 
2.4 Psychological measures 
Depressive symptoms were assessed with the German version of the Centre for Epidemiologic 
Studies Depression Scale (Allgemeine Depressionskala – Kurz), a 15 item self-report measure of 
depressive mood, which respondents scored on a 4-point Likert-type scale from 0 (never or very 
rarely) to 3 (always or nearly all the time) (Hautzinger & Bailer, 1993). A clinical cut-off score of 18 or 
above, with high specificity and sensitivity, indicates the presence of a depressive state. The 
Depression Scale is a widely used, quick instrument, and reliability and validity data have been 
documented for use within general and clinical populations (Lehr, Hillert, Schmitz, & Sosnowsky, 
2008). 
Subjective sleep was assessed using the self-report Insomnia Severity Index (ISI) (Bastien, Vallières, & 
Morin, 2001). The ISI aims to detect subthreshold (score of 8-14), mild (score of 15-21), and severe 
(score of 21-28) insomnia. Participants respond to seven questions on a 5-point Likert-type scale 
ranging from 0 (e.g., not at all) to 4 (e.g., very severe) concerning sleep quality, and impact and 
severity of any disturbances in the previous two weeks. The scale has excellent internal consistency 
and good convergent validity (Morin, Belleville, Belanger, & Ivers, 2011). 
Self-control was assessed using the Brief Self Control Scale (BSCS) (Maloney, Grawitch, & Barber, 
2012). The scale comprises 13 items measured on a 5-point Likert-type scale, with answers varying 
from 1 (not true) to 5 (completely true). This measure evaluates the responder’s tendency towards 
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traits and habits associated with high self-control. The BSCS has good internal consistency and retest 
reliability (Tangney, Baumeister, & Boone, 2004). 
The Perceived Stress Scale (PSS) (Cohen, Kamarck, & Mermelstein, 1983) was used to measure the 
degree to which respondents report various aspects of their life as stressful. Responses are given on 
a 5-point Likert scale ranging from 1 (never) to 5 (very often). The PSS has good reliability and validity 
(Roberti, Harrington, & Storch, 2006). 
The 36-item short-form health survey questionnaire (SF-36) encompasses eight multi-item 
dimensions of health (physical functioning, social functioning, physical problems, emotional 
problems, mental health, vitality, pain, and general health perception) (Brazier et al., 1992). The 
German version of the SF-36 shows good reliability and construct validity (Bullinger, 2000).  
2.5 Substance use 
Substance use was measured using the Timeline Follow-back (TLFB) questionnaire (Sobell & Sobell, 
1996). This calendar system, administered by an investigator, is used as a tool to help participants 
recall their consumption of substances, and the amount consumed, for the past 30 days. In the 
present study, specified substances were: cigarettes; alcohol; illicit medication; street heroin; 
cocaine; and other illicit substances such as marijuana and LSD. The total number of days on which 
any substances, excluding cigarettes and alcohol, were consumed, was also calculated. The TLFB has 
excellent reliability and validity (Hjorthøj, Hjorthøj, & Nordentoft, 2012; Sobell, Maisto, Sobell, & 
Cooper, 1979).  
2.6 Self-reported activity 
The International Physical Activity Questionnaire Short Form (IPAQ-SF) was used to assess the 
physical activity levels of participants over the previous seven days. This simple measure comprises 
six questions concerning the number of days, and minutes per day, on which respondents were 
vigorously, moderately and lightly physically active, respectively. The IPAQ-SF is easy and quick to 
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administer and has satisfactory validity (Craig et al., 2003; van Poppel, Chinapaw, Mokkink, van 
Mechelen, & Terwee, 2010). While it has been shown that the IPAQ-SF can lead to an overestimation 
of activity, its usefulness in repeated measures studies remains accepted, and the ease of use and 
internationally standardised versions make it an appropriate measure for the current study (Lee, 
Macfarlane, Lam, & Stewart, 2011). 
2.7 Physiological measures 
Blood pressure was taken using a digital sphygmamometer, following the protocol described by 
Pickering and colleagues (Pickering et al., 2005). Patients were seated, instructed to avoid speech and 
movement, and the measurement was carried out by study personnel. Three measures were taken, 
each separated by a minute, and the mean value was calculated for analysis. 
Hand grip strength was measured using a SH 5001 Hydraulic Hand Dynamometer (Saehan 
Corporation) calibrated by the manufacturer. Participants performed the test seated, following the 
detailed protocol described by Bellace (2000) and colleagues (Bellace, Healy, Besser, Byron, & 
Hohman, 2000). Three measurements for each hand were taken, alternating after each effort and 
rest period, and the mean value was calculated for analysis.  
The handgrip strength test represents a physiological measure which has been shown to predict the 
development of future health complications and premature mortality (Sasaki et al, 2007). Although in 
a study examining the effects of exercise, a more direct assessment of fitness change, such as VO2 
Max testing, is highly desirable, the difficulty of performing multiple laboratory tests with each 
participant, and the physical complaints experienced by some when walking briskly, rendered such 
testing unfeasible.  
2.8 Statistical analysis 
Demographic data was analysed using one-way univariate analysis of variance (ANOVA) and Chi-
squared tests. Physiological and psychological variables were analysed using repeated measures 
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ANOVAS, with the independent factors of Group (exercise vs. comparison) and Time (baseline, 6 
weeks, 12 weeks). Where Mauchly’s test of sphericity was significant, the Greenhouse-Geisser 
correction was applied. For all analyses, the level of significance was set at at p≤0.05. Cohen’s ω 
effect sizes for the Chi-squared tests and ANOVAS were interpreted as follows: >0.1, small; >0.3, 
medium; >0.5, large; and >0.01, small; >0.06,medium; >0.14, large, respectively (Cohen, 1977). 
Statistical analysis was performed using SPSS 21 (IBM Corporation, Armonk NY, USA) for Windows. 
An intention-to-treat analysis was not employed as, while a number of participants missed varying 
numbers of sessions, all participants completed the measures employed over the three 
measurements points. 
3. Results 
Following invitation, 22 patients indicated that they did not wish to participate in the study. Reasons 
cited were inability to participate at the time in question (n=4), unwillingness to commit to 12 weeks 
of participation (n=17), and unwillingness to participate without a guarantee that they would end up 
in the exercise group (n=1). Following randomisation, three members assigned to the comparison 
group and one assigned to the exercise group withdrew consent for the study. The remaining 24 
comprised 13 participants in the exercise group and 11 in the comparison group. 
Sociodemographic data for both groups is given in Table 1. The exercise group did not differ 
significantly from the comparison group on any aspect. The mean age and gender distribution 
reflects the current means of the HAT population in Switzerland (Hiltebrand, Dickson-Spillmann, 
Bolliger, & Schaub, 2015). 
Data on compliance with the study protocol and attendance per session can be found in Table 2 and 
Figure 1. There was a significant difference in compliance between the exercise and comparison 
groups. Members of the comparison group were more frequently non-compliant, and less frequently 
semi-compliant. The proportion of participants with high compliance was similar in both groups with 
39% (exercise) and 46% (comparison). 
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Results of the psychological assessments are shown in Table 3. The exercise group scored 
significantly better than the comparison group across all time points including baseline on the first 
dimension of the SF-36, which reflects physical functioning. A large effect size was observed for this 
variable. A medium effect size for time by group was also observed for the second dimension of the 
SF-36, which reflects limitations in usual activities due to physical problems. A large effect size for 
group was observed for the seventh dimension of the SF-36, which reflects limitations in usual 
activities because of emotional problems. Aside from this, there were no significant effects of time, 
group, or time by group.  
Findings for concomitant substance use are shown in Table 4. Medium effect sizes for time by group 
interaction were found for sum days of concomitant substance use, days of cigarette use, and days of 
illicit use of prescription drugs. There were no significant effects of time, group, or time by group.  
Data for self-reported activity and physiological variables are shown in Table 5. A significant time by 
group interaction effect and large effect size was observed for the number of minutes per day of 
vigorous physical activity, although not for the number of days per week on which this exercise was 
performed. A large effect size for group was also observed for the number of minutes per day spent 
on foot. There were no further significant effects observed for self-reported activity. However, 
descriptively, the exercise group reported a decrease in minutes per day spent in moderate exercise.  
The exercise group showed significantly greater right and left hand-grip strength, with large effect 
sizes for group, compared to the comparison group. Otherwise, there were no significant effects of 
time, group, or time by group on the physiological variables.  
4. Discussion 
The current study assessed the feasibility and acceptability of an exercise programme in a HAT 
setting, and further explored effects on a number of psychological, behavioural and physiological 
variables. Based on the findings, it can be concluded that an exercise intervention is both feasible 
and accepted in this setting. While no effects on psychological or physiological functioning were 
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observed, it is important to emphasise that an intervention with measurable effects, but which the 
target population does not want to take part it, is not a valuable addition to treatment. This study 
represents a first step towards to further integration of exercise in outpatient substance dependence 
treatment settings, which it is hoped will lead to a broader evidence base regarding the effects of 
exercise. 
Just under half of the patients invited to take part in the study participated. It can therefore be 
concluded that patients in this HAT clinic can be recruited to participate in an exercise programme. It 
must also be noted that HAT is an outpatient treatment, and the participation rates are all the more 
notable for the fact that patients took extra time out of their days to participate, rather than 
participating as a means to fill in time during inpatient treatment. However, it must also be noted 
that in a clinic of approximately 150 patients, 24 willing and able participants represents a rate of 
16%.  The voluntary nature of the study naturally means that mainly individuals already interested in 
exercise chose to participate; this level of bias is almost impossible to exclude in non-blinded 
research. This phenomenon may also partly be reflected in the significantly lower participation of 
the comparison group. Accordingly, it must be noted that while compliance levels were promising, 
the acceptability of such an intervention must be interpreted in light of the fact that many patients in 
a clinic of this kind may not be suitable candidates for an exercise programme. 
In the sole other study to examine the effects of exercise in patients receiving opioid substitution 
therapy, specifically methadone maintenance, it was concluded that active video-game play, an 
accepted form of physical exercise, was a feasible addition to treatment (Cutter et al, 2014). With 
23% of all clinic patients participating in the study, acceptability of this intervention can be deemed 
slightly higher, though not dissimilar, to our study. Interestingly, the comparison group in Cutter´s 
(2014) study, playing sedentary video games, appeared to be equally compliant with the study 
protocol compared to the exercise game players. It may be that video-games are a most promising 
comparison condition for research with this population. However, while decreases in secondary 
substance consumption and stress were reported in this study, there was no difference between 
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groups. While this very limited literature does not foster confident conclusions, it would appear that 
patients in opioid substitution treatment are willing to engage in exercise, and enjoy it, but the 
anticipated improvements in well-being are not measurable over time spans of a few months. 
Individuals in this form of treatment have, in the majority of cases, been substance dependent for a 
number of years, and consequently may require long term interventions to show any changes in 
physical or psychological status. Although challenging to engage in, studies which assess effects of 
such programmes over many months may provide evidence of measurable effects. 
Only 54.6% of comparison group members were compliant or semi-compliant with the study 
protocol, in spite of the fact that they were frequently reminded that they would receive 12 weeks of 
exercise training following the study period if they desired, and it was emphasised that this offer was 
not conditional upon attendance at a certain number of comparison meetings; equally, participation 
in this subsequent offer was not required, or associated with further analysis. On the one hand, this 
has the consequence that no further follow-up data is available; on the other, it was intended to 
ensure that participation in the comparison group was not negatively associated with the duty to 
commit to 24, rather than 12, weeks of research. Our finding suggests that a randomized study 
design may be complicated to implement in this population. Full blinding is impossible in such 
interventions, and the choice between a controlled trial, or a comparison trial, can impact on the 
study outcomes, and must therefore be guided by them. As outlined above, our rationale for 
including a comparison group which took part in outings with the study personnel was to minimise 
the potential confounding effects of contact time, access to special locations, and financial reward. 
Had the comparison group received only treatment as usual, any positive development observed in 
the exercise group would be questionable. A wait-list control condition represents a potential 
solution to this situation; however, our experience suggested that even this approach may cause 
problems for participant retention, as a number of individuals in this study refused to participate if it 
could not be guaranteed that they could begin exercise immediately, rather than in 12 weeks. 
Further, again as noted above, this doubles the commitment time for participants, a factor which 
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should not be underestimated during recruitment. An ITT analysis will be essential in such cases. 
Based on our study design and findings, we feel we can cautiously suggest that participating in 
exercise itself, and not just a somewhat lucrative study, may be judged to be attractive for HAT 
patients; subsequent studies may produce more significant results if they are able to combine 
successful recruitment with a randomized controlled design.  
In line with research questions 1.1, 1.2, and 1.3, it appears therefore appears that HAT participants 
can be recruited to such a study, and that compliance with the exercise protocol significantly 
exceeded compliance with the control  comparison condition. 
The present study implemented patient feedback to design the exercise programme, thus enabling 
patients to determine the type and intensity of activity they participated in. In addition to 
demonstrating respect for patient’s wishes, there is evidence that self-paced exercise results in more 
positive affective response than prescribed intensity exercise (Williams, 2008); this may be an 
important factor in maintaining adherence rates in this population.  
Although this approach may have had a favourable impact on participation rates, the decision to 
forgo testing of fitness parameters and training effects means that data regarding the physiological 
impact of the chosen methodology is not available; this holds true even when the data for handgrip 
strength are assessed. While handgrip strength has been associated with a number of health 
outcomes, as outlined in the Methods section, in this study there were no significant changes over 
time.  Despite the ease of testing handgrip strength, we acknowledge that this distal marker of health 
outcomes may be less reactive to a fitness intervention than VO2 Max testing, for example, which 
may be the next step for research in this setting. 
While it is difficult to speculate on the success of a longer-term exercise programme, we suggest that 
the regular participation of the sport group (as compared to the control group) in this study, and, 
importantly, the clinic structure in the HAT setting (daily patient contact, patient interaction) are key 
factors which may be positive indicators of long-term adherence.  Indeed, it is possible that a longer 
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term programme may lead to an increase in participation, as individuals initially unwilling to 
participate may be more likely to trust and accept an established programme recommended by 
peers. 
In line with the compliance of the exercise group with the study protocol, this group reported a 
significant increase in minutes per day spent in vigorous physical activities at the end of the study 
period. Consequently, it can be concluded that the increase in activity was received as such, and 
reliably reported, by this group. Participation in physical activity, especially vigorous physical activity, 
has a positive effect on all-cause mortality (Gebel et al., 2015; Hupin et al., 2015). Interestingly, the 
exercise group also reported a descriptively, but not significantly reduced level of minutes per day 
spent moderately exercising at the end of the study. It may be that this group perceived their 
participation in the programme to be strenuous, and therefore reduced other activities in order to 
rest and recover for the “official” exercise programme.  
There were no statistically significant effects observed for any of the other variables measured; 
research question 1.4 cannot be answered further. No data regarding the existence or effectiveness 
of hypothesised mechanisms of exercise as an adjunct treatment can be provided by this study. 
Improvements in these domains have been reported in other populations with mental disorders; it 
may be that changes would become significant with a larger sample, over a longer period of time, or 
with a structured training protocol, in the latter case especially where physiological changes are 
concerned.  
Future directions 
While the prevalence of opioid addiction has decreased in Switzerland and other European countries, 
the United States has recently experienced a resurgence, as the increase in opioid medication 
prescription has translated to increased rates of death associated with heroin (Dart  et al., 2015). The 
results of this study are that exercise is a feasible, acceptable and desirable addition to HAT, but that 
standardised tests and questionnaires detect no significant improvements in a number of physical 
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and psychological parameters. The exercise intervention implemented here did not adhere to any 
specific intensity guidelines. Consequently, the next step in examining exercise as a potential adjunct 
treatment is to investigate whether one or several strict exercise protocols would result in 
measurable improvements in these or other parameters. As suggested by Linke and Ussher (2015) 
explicit development of exercise as a tool to cope with difficult situations and improve psychological 
health should also be tested.  
Limitations 
The present study has a number of limitations. First, as a pilot study, sample size may have been too 
small to detect some intervention effects. Second, the decision was made to allow patients to freely 
select the type and intensity of activity they participated in; hence, no associations between specific 
forms of exercise bout and the results presented here can be made. Self-report of physical activity, as 
noted above, may be unreliable, and future full scale studies may manage this issue by using 
objective physical activity trackers or cardiorespiratory fitness tests. Baseline differences were not 
included as covariates in the statistical analysis: While this renders the interpretation of treatment 
effects less clear, this approach was chosen to reflect the assessment of repeated measurements 
following the initial assessment. Finally, the decision to categorise individuals who attended between 
17 and 5 sessions as “semi-compliant” means that a broad range of attendance was represented in 
this category, which could distort the findings. While it was felt that in this case, breaking the already 
small sample into further groups would be equally problematic, future studies may seek to pre-
define more specific categories to permit a more detailed analysis.  
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Figure 1. Participant numbers for each of the 23 intervention sessions, separately for exercise 
condition and comparison condition 
 
Note: N=24(EX : n=13 ; Comparison: n=11). EX: exercise conditio
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Table 1.Descriptive and Inferential Statistics for Demographic Variables, separately for exercise 
condition and control condition 
 EX (n=13) Control (n=11)   
 M (SD) M (SD) F          p 
Age (Years) 42.7(6.5) 45.8(4.2) 1.73 .201 
Diacetylmorphine 
dose per day 
(mg) 
377 (164) 400 (162) .066 .802 
 N (%) N (%) χ
2
 p 
Women 4 (30.8) 5 (37.5) .548 .459 
Men 9 (69.2) 6 (62.5)   
Employed 4(30.8) 1(9.1) 1.968 .193 
Unemployed 9(69.2) 10(90.9)   
Education 
beyond high 
school 
8(61.5) 6(54.5) .120 .729 
No education 
beyond high 
school 
5(38.5) 5(45.5)   
Single 8(61.5) 9(81.8) 1.570 .456 
Married 1(7.7) 0(0.0)   
Divorced 4(30.8) 2(18.2)   
Psychiatric 
comorbidity 
diagnosed 
6(46.2) 6(54.5) .168 .682 
No psychiatric 
comorbidity 
diagnosed 
 
7(53.8) 5(45.5)   
Note: N=24. EX= Exercise condition
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Table 2. Descriptive and Inferential Statistics for Compliance rates, separately for exercise and control 
conditions 
 EX (n=13) Control (n=11)   
 N (%) N (%) χ
2
 p 
Compliant 5 (38.5) 5 (45.5) 7.049 .029 
Semi-Compliant 7 (53.8) 1 (9.1)   
Non-Compliant 1 (7.7) 5 (45.5)   
 Note: N=24. EX= Exercise condition.Compliant: Missed fewer than 5 of 23 sessions. Semi-Compliant: 
Missed between 6 and 18 of 23 sessions. Non-Compliant: Missed 19 or more of 23 sessions.  
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Table 3. Descriptive and Inferential statistics for Depression, Subjective Sleep, Self-Control, Perceived Stress, and 
Quality of Life, separately for exercise condition and control condition. 
 Group Baseline 
M (SD) 
6 Weeks 
M (SD) 
12 Weeks 
M (SD) 
F (P Value) 
η2 
Time effect 
F (P Value) 
η2 
Group 
Effect 
F (P Value) 
η2 
Interaction 
effect 
ADS EX 15.23(11.42) 13.31(9.74) 13.54(10.83) .930(.403) 
.044 
.452(.509) 
.022 
.301(.742) 
.015 
 Control 17.44(6.78) 17.11(6.25) 15.11(9.07)    
ISI EX 12.00(7.52) 11.85(8.255) 11.08(7.66) 2.371(.106) 
.106 
1.380(.254) 
.065 
.636(.535) 
.031 
 Control 9.67(5.45) 8.00(5.172) 7.33(3.77)    
BSC EX 38.85(6.90) 40.46(8.35) 40.85(6.42) 1.546(.230) 
.072 
.603(447) 
.029 
2.760(.093) 
.121 
 Control 
 
39.22(8.72) 35.00(7.17) 39.00(8.44)    
PSS EX 
 
16.92(8.09) 17.31(7.67) 17.15(7.35) .071(.931) 
.004 
.452(.509) 
.025 
.157(.855) 
.008 
 Control 
 
19.33(6.25) 18.89(7.11) 19.67(6.80)    
SF36 
- 1 
EX 95.77(5.34) 86.92(13.31) 91.92(8.04) 1.609(.213) 
.074 
6.951(.016) 
.258 
.564(.574) 
.027 
 Control 77.78(16.97) 75.56(22.14) 77.78(23.33)    
SF36 
- 2 
EX 75.00(22.82) 73.08(43.85) 59.62(43.94) .332(.720) 
.016 
1.343(.260) 
.063 
1.307(.282) 
.061 
 Control 44.44(37.03) 58.33(41.45) 58.33(43.30)    
SF36 
- 4 
EX 60.23(24.91) 64.92(22.34) 60.92(25.80) .386(.681) 
.019 
.604(.446) 
.029 
.492(.615) 
.024 
 Control 54.11(14.69) 55.22(13.70) 58.22(9.74)    
SF36-
5 
EX 50.00(20.20) 45.77(14.97) 46.54(18.75) .376(.689) 
.018 
1.208(.285) 
.057 
.416(.663) 
.020 
 Control 40.56(13.33) 41.67(16.00) 38.89(14.53)    
SF36-
6 
EX 71.15(27.18) 79.81(25.78) 76.92(20.31) 1.563(.222) 
.073 
.990(.332) 
.047 
1.018(.370) 
.048 
 Control 66.67(24.20 69.44(20.83) 62.50(27.24)    
SF36-
7 
EX 53.85(37.36) 64.10(37.172) 64.15(37.20) 1.984(.151) 
.090 
3.408(.080) 
.146 
1.101(.343) 
.052 
 Control 29.63(45.47) 44.45(37.26) 25.93(36.46)    
SF36-
8 
EX 60.92(20.85) 60.92(25.72) 64.92(24.88) .676(.514) 
.033 
.572(.458) 
.028 
.596(.556) 
.029 
 Control 53.33(18.54) 57.33(19.07) 55.56(19.53)    
Note: N=24(EX : n=13 ; Control: n=11). EX: exercise condition. ADS: Allgemeine Depressionsskala – Kurz. ISI: 
Insomnia Severity Index. BSC: Brief Self Control Scale. PSS: Perceived Stress Scale. SF36 1-8: Short Form Health 
Survey Questionnaire
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Table 4. Descriptive and Inferential Statistics for Secondary Substance Consumption, separately for exercise 
condition and control condition. 
 Group Baseline 
M(SD) 
6 weeks 
M(SD) 
12 weeks 
M(SD) 
F (P Value) 
η2 
Time effect 
F (P Value) 
η2 
Group 
Effect 
F (P Value) 
η2 
Interaction 
effect 
Days 
secondary 
drug 
consumption 
EX 8.92(8.91) 9.85(9.92) 7.85(9.91) .672(.516) 
.031 
.655(.427) 
.030 
1.631(.208) 
.072 
 Control 14.60(13.77) 9.50(12.89) 12.90(13.32)    
Days illicit 
heroin 
consumption 
EX .23(.59) .31(.85) .46(1.19) .013(.953) 
.001 
1.001(.328) 
.046 
.828(.402) 
.038 
 Control .20(.42) .10(.31) .00(.00)    
Days illicit 
cocaine 
consumption 
EX 1.38(2.21) 3.08(7.63) .38(1.12) .888(.362) 
.041 
.309(.584) 
.015 
1.158(.297) 
.052 
 Control 3.00(8.80) 3.00(8.80) 3.20(8.74)    
Days alcohol 
consumption 
EX 7.08(8.86) 5.92(8.60) 7.69(10.01) 2.125(.132) 
.092 
.962(.338) 
.044 
.701(.502) 
.032 
 Control 5.90(8.60) .90(1.66) 4.50(8.78)    
Days 
cigarette 
consumption 
EX 27.38(2.21) 28.00(.00) 28.00(.00) .741(.483) 
.034 
1.023(.323) 
.046 
1.811(.176) 
.079 
 Control 28.00(.00) 25.20(8.85) 25.20(8.85)    
Days 
unprescribed 
medication 
consumption 
EX 1.46(2.60) .38(1.38) .08(.277) 2.204(.138) 
.095 
2.043(.168) 
.089 
2.204(.095) 
.095 
 Control .10(.316) .10(.316) .10(.316)    
Note: N=24 (EX : n=13 ; Control: n=11). EX: exercise condition. 
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Table 5. Descriptive and Inferential statistics for Self-reported activity and physiological measures, separately  
for exercise and control conditions. 
 
Note: N=24(EX : n=13 ; Control: n=11).. EX: exercise condition. IPAQ1-6: International Physical Activity 
Questionnaire 
 
 Group Baseline 
M(SD) 
6 Weeks 
M(SD) 
12 Weeks 
M(SD) 
F (P Value) 
η2 
Time effect 
F (P Value) 
η2 
Group 
Effect 
F (P Value) 
η2 
Interaction 
effect 
IPAQ – 1 EX 1.15(1.46) 1.92(1.70) 4.08(8.79) .628(.451) 
.030 
1.050(.318) 
.050 
.989(.339) 
.047 
 Control 1.11(1.61) 1.44(2.65) .89(1.69)    
IPAQ – 2 EX 23.08(27.12) 41.54(39.28) 36.92(29.12) .293(.682) 
.014 
.870(.362) 
.042 
3.794(.046) 
.159 
 Control 28.33(34.73) 15.00(27.04) 23.33(36.82)    
IPAQ – 3 EX 2.54(2.78) 3.92(3.22) 
 
3.00(2.30) 1.345(.272) 
.063 
2.133 (.160) 
.096 
.766(.472) 
.037 
 Control 2.22(2.38) 2.33(2.82) 1.22(1.09)    
IPAQ – 4 EX 68.08(97.33) 75.00(90.83) 41.54(31.31) .505(.607) 
.025 
1.721(.204) 
.096 
.773(.468) 
.037 
 Control 35.00(34.36) 30.00(35.17) 35.00(35.96)    
IPAQ – 5 EX 6.08(2.29) 6.38(1.44) 5.08(2.53) 2.758(.101) 
.121 
.378(.546) 
.019 
.103(.903) 
.005 
 Control 5.44(2.60) 5.67(2.69) 4.78(3.15)    
IPAQ - 6 EX 71.54(56.84) 84.23(68.06) 68.08(59.56) .377(.629) 
.018 
3.404(.080) 
.145 
.434(.595) 
.021 
 Control 41.67(20.91) 40.00(16.77) 40.00(23.71)    
Systolic 
pressure 
EX 131.67(16.79) 129.76(18.89) 130.48(18.57) 1.145(.329) 
.054 
.007(.963) 
.000 
1.152(.326) 
 
 Control 133.00(13.63) 134.27(17.09) 126.31(18.78)    
Diastolic 
pressure 
EX 85.30(9.24) 82.46(10.70 84.87(14.32) .962(.391) 
.046 
.105(.750) 
.005 
.013(.987) 
.001 
 Control 87.11(9.05) 83.53(13.10) 86.09(12.77)    
Handgrip 
right 
EX 45.53(12.34) 43.25(10.63) 44.38(9.12) .101(.849) 
.005 
5.558(.029) 
.217 
1.550(.229) 
.072 
 Control 
 
32.66(10.56) 36.48(11.22) 34.33(10.09)    
Handgrip 
left 
EX 42.94(10.69) 41.38(8.92) 43.64(7.20) .827(.397) 
.040 
8.709(.008) 
.303 
.179(.730) 
.009 
 Control 31.74(9.16) 31.25(9.19) 32.11(9.61)    
